Rifampin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rifampin Injection (injection) from Mylan Institutional, a Viatris Company with status Current. The shortage was first posted on 02/17/2021. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- Mylan Institutional, a Viatris Company
- Package NDC
- 67457-445-60
- Dosage Form
- Injection
- Presentation
- Rifampin, Injection, 600 mg/10 mL (NDC 67457-445-60)
- Initial Posting
- 02/17/2021
- Revised Date
Reason
Demand increase for the drug